Research News in Life Sciences

Big Pharma struck out. So NIH is giving IU, Purdue millions to seek new Alzheimer’s treatments

Indianapolis Star - Oct. 2, 2019

The Indiana University School of Medicine has received a five-year, $36 million National Institutes of Health grant to create a novel drug discovery center focused on finding new treatments for Alzheimer’s disease.

The center, which will work in partnership with Purdue University’s Institute for Drug Discovery, is one of only two such entities in the country. The other one includes researchers from Emory University, Seattle, Canada and the United Kingdom.

Life science companies can learn from failure if they stay flexible, experts say

Indianapolis Business Journal - May 3, 2019

Sometimes the toughest call a life-sciences startup can make is when to drop a long-favored project that just isn't cutting it and come up with Plan B. In the case of Endocyte Inc., a West Lafayette company that had been trying for more than two decades to develop smart cancer drugs, the moment came about two years ago, when the firm announced it was halting tests of a leading compound and laying off 40 percent of its staff.

Indiana Biosciences Research Institute licenses Purdue technologies under university agreement

Purdue Research Foundation News - November 8, 2017

The Indiana Biosciences Research Institute on Wednesday announced it has licensed two Purdue University life sciences technologies through the Purdue Research Foundation Office of Technology Commercialization. The technologies the IBRI has licensed include a mass spectrometry technology and a high-sensitivity detection technology for single cell analysis developed at Purdue. They will be used in research being done by the IBRI’s Single Cell Analytics Center, led by Dr. Michael Pugia.

Expanding Life Sciences: Purdue University

Discovery Park - August 31, 2017

With their recent $250 million investment in the life sciences, Purdue has created three new Life Sciences Institutes that build upon their strength in the biological sciences. Coupled with the premier Bioanalysis Hub, the Bindley Bioscience Center in Discovery Park, Purdue is a world leader in Zika virus research, translational drug discovery, and new tool development in analytical chemistry.

Lilly, Purdue Partner on Life Sciences Research

INside Indiana Business - July 6, 2017

Eli Lilly and Co. and Purdue University are forming a strategic life sciences research collaboration. Lilly will provide up to $52 million to fund research over five years, marking Purdue's largest strategic collaboration with a single company.

Lilly and Purdue University announce strategic research collaboration

Purdue University Newsroom - July 6, 2017

Eli Lilly and Company (NYSE: LLY) and Purdue University on Thursday (July 6) announced a strategic collaboration to conduct life science research. The five-year agreement, where Lilly will provide up to $52 million, marks Purdue’s largest strategic collaboration with a single company.